1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Material Type Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Rise in Expenditure
4.1.2. Increased Per Capita Expenditure
4.2. Forecast Factors – Relevance & Impact
4.2.1. Material Type in Pipeline
4.2.2. Regulatory Scenario
4.2.3. Mergers and Acquisitions
4.2.4. Collaborative Agreements
4.2.5. Value Chain
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.4. COVID19 Crisis Analysis
4.4.1. Current COVID19 Statistics and Probable Future Impact
4.4.2. Current GDP Projection and Probable Impact
4.4.3. Current Economic Projection as Compared to 2008 Economic analysis
4.4.4. COVID19 and Impact Analysis
4.4.4.1. Revenue By Material Type
4.4.4.2. Revenue By Aneurysm Indication
4.4.4.3. Revenue By Aneurysm Type
4.4.4.4. Revenue By Disease Indication
4.4.4.5. Revenue By End User
4.4.4.6. Revenue By Country
4.4.5. 2020 Market Scenario
4.4.6. Quarter by Quarter Forecast
4.4.7. Projected Recovery Quarter
4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
5. Market Context
5.1. Adoption and Usage Analysis
5.2. Market Evolution
5.3. Material Type Vs Aneurysm Indication Matrix
5.4. Regulatory Scenario
5.5. Parent Market Analysis
5.6. Key Promotional Strategies by Market Players
6. Global Market – Pricing Analysis
6.1. Regional Pricing Analysis By Material Type
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
7.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
8.1. Introduction / Key Findings
8.2. Historical Market Disease Indication (US$ Mn) Analysis By Material Type, 2018 to 2023
8.3. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Material Type, 2024 to 2034
8.3.1. Titanium Alloy
8.3.2. Cobalt-chromium Alloy
8.4. Market Attractiveness Analysis By Material Type
9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Aneurysm Type
9.1. Introduction / Key Findings Aneurysm Type Disease Indication, 2018 to 2023
9.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Aneurysm Type, 2024 to 2034
9.2.1. Cerebral
9.2.2. Thoracic
9.2.3. Abdominal
9.2.4. Peripheral
9.3. Market Attractiveness Analysis By Aneurysm Type
10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Aneurysm Indication
10.1. Introduction / Key Findings Aneurysm Indication Disease Indication, 2018 to 2023
10.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Aneurysm Indication, 2024 to 2034
10.2.1. Saccular Aneurysm
10.2.2. Fusiform Aneurysm
10.3. Market Attractiveness Analysis By Aneurysm Indication
11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Disease Indication
11.1. Introduction / Key Findings Disease Indication, 2018 to 2023
11.2. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By Disease Indication, 2024 to 2034
11.2.1. Tumor & Brain Cancer
11.2.2. Brain Arteriovenous Malformations
11.2.3. Ischemic Stroke
11.2.4. Brain Aneurysm
11.3. Market Attractiveness Analysis By Disease Indication
12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Disease Indication (US$ Mn) Analysis By End User, 2018 to 2023
12.3. Current and Future Market Disease Indication (US$ Mn) Analysis and Forecast By End User, 2024 to 2034
12.3.1. Hospitals
12.3.2. Cardiac Centers
12.3.3. Specialty Clinics
12.3.4. Research Centers
12.3.5. Others
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
13.1. Introduction
13.2. Historical Market Disease Indication (US$ Mn) Analysis By Region, 2018 to 2023
13.3. Current Market Disease Indication (US$ Mn) Analysis and Forecast By Region, 2024 to 2034
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023
14.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. United States
14.3.1.2. Canada
14.3.2. By Material Type
14.3.3. By Aneurysm Type
14.3.4. By Aneurysm Indication
14.3.5. By Disease Indication
14.3.6. By End User
14.4. Market Attractiveness Analysis
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023
15.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. United Kingdom
15.3.1.5. Spain
15.3.1.6. Rest of Europe
15.3.2. By Material Type
15.3.3. By Aneurysm Type
15.3.4. By Aneurysm Indication
15.3.5. By Disease Indication
15.3.6. By End User
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
16. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023
16.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. South Africa
16.3.1.3. Rest of Middle East and Africa
16.3.2. By Material Type
16.3.3. By Aneurysm Type
16.3.4. By Aneurysm Indication
16.3.5. By Disease Indication
16.3.6. By End User
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
17. Rest of the World Market Analysis 2018 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Disease Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023
17.3. Market Disease Indication (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034
17.3.1. By Material Type
17.3.2. By Aneurysm Type
17.3.3. By Aneurysm Indication
17.3.4. By Disease Indication
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
18. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. United States Market Analysis
18.2.1. By Material Type
18.2.2. By Aneurysm Type
18.2.3. By Aneurysm Indication
18.2.4. By Disease Indication
18.2.5. By End User
18.3. Canada Market Analysis
18.3.1. By Material Type
18.3.2. By Aneurysm Type
18.3.3. By Aneurysm Indication
18.3.4. By Disease Indication
18.3.5. By End User
18.4. United Kingdom Market Analysis
18.4.1. By Material Type
18.4.2. By Aneurysm Type
18.4.3. By Aneurysm Indication
18.4.4. By Disease Indication
18.4.5. By End User
18.5. Germany Market Analysis
18.5.1. By Material Type
18.5.2. By Aneurysm Type
18.5.3. By Aneurysm Indication
18.5.4. By Disease Indication
18.5.5. By End User
18.6. France Market Analysis
18.6.1. By Material Type
18.6.2. By Aneurysm Type
18.6.3. By Aneurysm Indication
18.6.4. By Disease Indication
18.6.5. By End User
18.7. Italy Market Analysis
18.7.1. By Material Type
18.7.2. By Aneurysm Type
18.7.3. By Aneurysm Indication
18.7.4. By Disease Indication
18.7.5. By End User
18.8. Spain Market Analysis
18.8.1. By Material Type
18.8.2. By Aneurysm Type
18.8.3. By Aneurysm Indication
18.8.4. By Disease Indication
18.8.5. By End User
18.8.6. By End User
18.9. GCC Countries Market Analysis
18.9.1. By Material Type
18.9.2. By Aneurysm Type
18.9.3. By Aneurysm Indication
18.9.4. By Disease Indication
18.9.5. By End User
18.10. South Africa Market Analysis
18.10.1. By Material Type
18.10.2. By Aneurysm Type
18.10.3. By Aneurysm Indication
18.10.4. By Disease Indication
18.10.5. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Material Type foot print by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. B. Braun Melsungen AG
20.3.1.1. Overview
20.3.1.2. Material Type Portfolio
20.3.1.3. Analyst Commentary
20.3.1.4. Key Financials
20.3.1.5. Recent Developments
20.3.1.6. Sales Footprint
20.3.1.7. Strategy Overview
20.3.1.7.1. Marketing Strategy
20.3.1.7.2. Material Type Strategy
20.3.1.7.3. Channel Strategy
20.3.2. Peter LAZIC GmbH
20.3.2.1. Overview
20.3.2.2. Material Type Portfolio
20.3.2.3. Analyst Commentary
20.3.2.4. Key Financials
20.3.2.5. Recent Developments
20.3.2.6. Sales Footprint
20.3.2.7. Strategy Overview
20.3.2.7.1. Marketing Strategy
20.3.2.7.2. Material Type Strategy
20.3.2.7.3. Channel Strategy
20.3.3. KLS Martin Group
20.3.3.1. Overview
20.3.3.2. Material Type Portfolio
20.3.3.3. Analyst Commentary
20.3.3.4. Key Financials
20.3.3.5. Recent Developments
20.3.3.6. Sales Footprint
20.3.3.7. Strategy Overview
20.3.3.7.1. Marketing Strategy
20.3.3.7.2. Material Type Strategy
20.3.3.7.3. Channel Strategy
20.3.4. Adeor Medical AG
20.3.4.1. Overview
20.3.4.2. Material Type Portfolio
20.3.4.3. Analyst Commentary
20.3.4.4. Key Financials
20.3.4.5. Recent Developments
20.3.4.6. Sales Footprint
20.3.4.7. Strategy Overview
20.3.4.7.1. Marketing Strategy
20.3.4.7.2. Material Type Strategy
20.3.4.7.3. Channel Strategy
20.3.5. Rebstock Instruments GmbH
20.3.5.1. Overview
20.3.5.2. Material Type Portfolio
20.3.5.3. Analyst Commentary
20.3.5.4. Key Financials
20.3.5.5. Recent Developments
20.3.5.6. Sales Footprint
20.3.5.7. Strategy Overview
20.3.5.7.1. Marketing Strategy
20.3.5.7.2. Material Type Strategy
20.3.5.7.3. Channel Strategy
20.3.6. Mizuho America
20.3.6.1. Overview
20.3.6.2. Material Type Portfolio
20.3.6.3. Analyst Commentary
20.3.6.4. Key Financials
20.3.6.5. Recent Developments
20.3.6.6. Sales Footprint
20.3.6.7. Strategy Overview
20.3.6.7.1. Marketing Strategy
20.3.6.7.2. Material Type Strategy
20.3.6.7.3. Channel Strategy
20.3.7. Stryker Corporation
20.3.7.1. Overview
20.3.7.2. Material Type Portfolio
20.3.7.3. Analyst Commentary
20.3.7.4. Key Financials
20.3.7.5. Recent Developments
20.3.7.6. Sales Footprint
20.3.7.7. Strategy Overview
20.3.7.7.1. Marketing Strategy
20.3.7.7.2. Material Type Strategy
20.3.7.7.3. Channel Strategy
20.3.8. RauMedic
20.3.8.1. Overview
20.3.8.2. Material Type Portfolio
20.3.8.3. Analyst Commentary
20.3.8.4. Key Financials
20.3.8.5. Recent Developments
20.3.8.6. Sales Footprint
20.3.8.7. Strategy Overview
20.3.8.7.1. Marketing Strategy
20.3.8.7.2. Material Type Strategy
20.3.8.7.3. Channel Strategy
20.3.9. InoMed
20.3.9.1. Overview
20.3.9.2. Material Type Portfolio
20.3.9.3. Analyst Commentary
20.3.9.4. Key Financials
20.3.9.5. Recent Developments
20.3.9.6. Sales Footprint
20.3.9.7. Strategy Overview
20.3.9.7.1. Marketing Strategy
20.3.9.7.2. Material Type Strategy
20.3.9.7.3. Channel Strategy
20.3.10. Codman & Shurtleff
20.3.10.1. Overview
20.3.10.2. Material Type Portfolio
20.3.10.3. Analyst Commentary
20.3.10.4. Key Financials
20.3.10.5. Recent Developments
20.3.10.6. Sales Footprint
20.3.10.7. Strategy Overview
20.3.10.7.1. Marketing Strategy
20.3.10.7.2. Material Type Strategy
20.3.10.7.3. Channel Strategy
20.3.11. evonos GmbH & Co. KG
20.3.11.1. Overview
20.3.11.2. Material Type Portfolio
20.3.11.3. Analyst Commentary
20.3.11.4. Key Financials
20.3.11.5. Recent Developments
20.3.11.6. Sales Footprint
20.3.11.7. Strategy Overview
20.3.11.7.1. Marketing Strategy
20.3.11.7.2. Material Type Strategy
20.3.11.7.3. Channel Strategy
20.3.12. Integra LifeSciences
20.3.12.1. Overview
20.3.12.2. Material Type Portfolio
20.3.12.3. Analyst Commentary
20.3.12.4. Key Financials
20.3.12.5. Recent Developments
20.3.12.6. Sales Footprint
20.3.12.7. Strategy Overview
20.3.12.7.1. Marketing Strategy
20.3.12.7.2. Material Type Strategy
20.3.12.7.3. Channel Strategy
20.3.13. Boston Scientific
20.3.13.1. Overview
20.3.13.2. Material Type Portfolio
20.3.13.3. Analyst Commentary
20.3.13.4. Key Financials
20.3.13.5. Recent Developments
20.3.13.6. Sales Footprint
20.3.13.7. Strategy Overview
20.3.13.7.1. Marketing Strategy
20.3.13.7.2. Material Type Strategy
20.3.13.7.3. Channel Strategy
20.3.14. Medtronic
20.3.14.1. Overview
20.3.14.2. Material Type Portfolio
20.3.14.3. Analyst Commentary
20.3.14.4. Key Financials
20.3.14.5. Recent Developments
20.3.14.6. Sales Footprint
20.3.14.7. Strategy Overview
20.3.14.7.1. Marketing Strategy
20.3.14.7.2. Material Type Strategy
20.3.14.7.3. Channel Strategy
20.3.15. Abbott
20.3.15.1. Overview
20.3.15.2. Material Type Portfolio
20.3.15.3. Analyst Commentary
20.3.15.4. Key Financials
20.3.15.5. Recent Developments
20.3.15.6. Sales Footprint
20.3.15.7. Strategy Overview
20.3.15.7.1. Marketing Strategy
20.3.15.7.2. Material Type Strategy
20.3.15.7.3. Channel Strategy
20.3.16. Ortho-Medical GmbH
20.3.16.1. Overview
20.3.16.2. Material Type Portfolio
20.3.16.3. Analyst Commentary
20.3.16.4. Key Financials
20.3.16.5. Recent Developments
20.3.16.6. Sales Footprint
20.3.16.7. Strategy Overview
20.3.16.7.1. Marketing Strategy
20.3.16.7.2. Material Type Strategy
20.3.16.7.3. Channel Strategy
20.3.17. MicroVention
20.3.17.1. Overview
20.3.17.2. Material Type Portfolio
20.3.17.3. Analyst Commentary
20.3.17.4. Key Financials
20.3.17.5. Recent Developments
20.3.17.6. Sales Footprint
20.3.17.7. Strategy Overview
20.3.17.7.1. Marketing Strategy
20.3.17.7.2. Material Type Strategy
20.3.17.7.3. Channel Strategy
20.3.18. Balt Extrusion
20.3.18.1. Overview
20.3.18.2. Material Type Portfolio
20.3.18.3. Analyst Commentary
20.3.18.4. Key Financials
20.3.18.5. Recent Developments
20.3.18.6. Sales Footprint
20.3.18.7. Strategy Overview
20.3.18.7.1. Marketing Strategy
20.3.18.7.2. Material Type Strategy
20.3.18.7.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Table 01: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material TypeTable 02: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 03: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 04: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 05: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 06: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication Age Group
Table 07: Global Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
Table 08: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 10: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 11: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 12: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 13: North America Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 14: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 16: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 17: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 18: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 19: Europe Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 20: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 22: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 23: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 24: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 25: Middle East and Africa Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 26: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Material Type
Table 27: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Indication
Table 28: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Aneurysm Type
Table 29: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Disease Indication
Table 30: Rest of the World Market Disease Indication (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
